APA (7th ed.) Citation

Romaguera, R., Salinas, P., Gomez-Lara, J., Brugaletta, S., Gómez-Menchero, A., Romero, M. A., . . . Gómez-Hospital, J. A. (2022). Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial. European heart journal, 43(13), 1320-1330. https://doi.org/10.1093/eurheartj/ehab790

Chicago Style (17th ed.) Citation

Romaguera, Rafael, et al. "Amphilimus- Vs. Zotarolimus-eluting Stents in Patients with Diabetes Mellitus and Coronary Artery Disease: The SUGAR Trial." European Heart Journal 43, no. 13 (2022): 1320-1330. https://doi.org/10.1093/eurheartj/ehab790.

MLA (9th ed.) Citation

Romaguera, Rafael, et al. "Amphilimus- Vs. Zotarolimus-eluting Stents in Patients with Diabetes Mellitus and Coronary Artery Disease: The SUGAR Trial." European Heart Journal, vol. 43, no. 13, 2022, pp. 1320-1330, https://doi.org/10.1093/eurheartj/ehab790.